Medtronic - MITG
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Medtronic - MITG sits in the top decile of US sponsors by registered trial count (#218 of 15,742 sponsors by registered trial count).
Medtronic - MITG: 119 sponsored US clinical trials, 5 recruiting.
Medtronic - MITG sponsors 119 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 99 completed. 5 of these trials are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Hypoxia, with 3 trials.
Top-decile sponsor footprint
Medtronic - MITG ranks in the top decile of sponsors by registered trial count (#218 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
99 of 109 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (90.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
119 total, page 3 of 3
SILS™ Port Laparoscopic Cholecystectomy Post Market Study
NCT00832767
Diagnosis of Intestinal Motility by Image Analysis Using Capsule Endoscopy
NCT01085513
AbsorbaTack Evaluation of Postoperative Pain Following Laparoscopic Hernia Repair
NCT00749268
Evaluation of the PillCam™ Colon Capsule Endoscopy (PCCE) Preparation and Procedure
NCT00885235
A Multi-Center Study to Assess the Performance of Saturation Patterns.
NCT00775346
ADVANCE: Assessment for Defining Variability in Anesthesia Through Novel Clinical EEG
NCT00689130
DSS: Diabetes Surgery Study - Intensive Medical Management of Type 2 Diabetes, With and Without Gastric Bypass Surgery
NCT00641251
PillCam® ESO 2 in Esophageal Pathologies
NCT00885469
Evaluation of Capsule Endoscopy in Patients With Suspected Crohn's Disease
NCT00487396
HALO Patient Registry: Ablation of Barrett's Esophagus
NCT00848237
Evaluation of the PillCam™ Colon Capsule Endoscopy (PCCE) in the Visualization of the Colon
NCT00440791
Ablation of Intestinal Metaplasia Containing Dysplasia
NCT00282672
EEG Biomarkers for Predicting Response to Antidepressant Therapy
NCT00289523
CARE--Childhood Awareness and Recall Evaluation
NCT00308984
Suture Granuloma in Body Contouring Surgery
NCT00223132
"Evaluation of the PillCam™ESO Capsule in the Detection of Esophageal Varices
NCT00481416
Treatment for Stress and Mixed Urinary Incontinence and Vaginal Vault Prolapse
NCT00223106
Comparison of Absorbable Sutures in Perineal Laceration Repair
NCT00223119
Performance Evaluation of Capsule Endoscopy in the Diagnosis of Gluten Sensitive Enteropathy (MA-23)
NCT00555737
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 2 |
| Phase 3 | 1 |
| Phase 4 | 4 |
What is open in the Medtronic - MITG pipeline
5 recruiting of 119 indexed (4% open); 99 completed (83%).
Phase mix: 5 late (III/IV) vs 5 early (I/II) (balanced across stages).
Top condition: Hypoxia (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Medtronic - MITG: open-pipeline peers nationwide
Peers matched on 119 registered trials and 4% open enrollment, not the therapeutic-area sidebar.
Medtronic - MITG sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 119 trials (± recruiting share)
- Children's Hospital Los Angeles · 119 trials · 29% recruiting
- Jaeb Center for Health Research · 119 trials · 14% recruiting
- Michigan State University · 120 trials · 20% recruiting
- San Diego State University · 118 trials · 27% recruiting
Sponsors near 4% open enrollment (± trial volume)
- National Institute on Drug Abuse (NIDA) · 4% recruiting · 335 trials
- Akebia Therapeutics · 4% recruiting · 24 trials
- Dentsply Sirona Implants and Consumables · 4% recruiting · 24 trials
- Smith & Nephew · 4% recruiting · 72 trials
Related
What to do with this Medtronic - MITG page
119 registered trials is a research-attention snapshot, not an endorsement of Medtronic - MITG or any single study.
- 5 of Medtronic - MITG's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Hypoxia is the condition Medtronic - MITG studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Hypoxia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Medtronic - MITG pipeline card: 119 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.